Skip to content

Comparison the recovery of alfentanil and fentanyl in combination with propofol after gastrointestinal endoscopy

Comparison the recovery of alfentanil and fentanyl in combination with propofol after gastrointestinal endoscopy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-12002575
Enrollment
Unknown
Registered
2012-10-18
Start date
2008-07-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Intravenous Sedation

Interventions

1:Alfentanil

Sponsors

Department of Anesthesiology, Buddhist Tzu Chi General Hospital, Taichung Branch
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 99 Years

Inclusion criteria

Inclusion criteria: (1) Age equal or greater than 20 years; (2) Patients select gastrointestinal and colonosocpic endoscopy for health examination; (3) Patient has given informed consent and must be able to sign informed consent; (4) ASA 1-3.

Exclusion criteria

Exclusion criteria: (1) Allergy to propofol, soybeans or eggs; (2) American Society of Anesthesiology (ASA) risk Class 4 or higher; (3) Permanent therapy with an opioid equivalent drug for any reason within 12 months (duration longer than 2 weeks); (4) Severe psychiatric or neurologic diseases; (5) Lack of compliance or pregnancy; (6) Drug and/or alcohol abuse; (7) Current immunosuppressive therapy (more than 40mg of a corticoid per day or azathioprine); (8) Chemotherapy with 2 weeks; (9) Radiotherapy; (10) History of gastric, colonic or rectal resection; (11) Patients referred because of gastrointestinal symptoms, iron-deficiency anemia, positive fecal occult blood test results, or any other diagnostic purpose.

Design outcomes

Primary

MeasureTime frame
Recovery Time;Patients' satisfaction score according to a visual;Dose of propofol consumed;Complications;Cost benefit analysis;

Countries

China

Contacts

Public ContactWai-Meng Ho
wmho@tzuchi.com.tw+886 04 36060666-3234

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Mar 25, 2026